Biomarker Study - 42756493BLC0002

• Research type

  Research Study

• Full title

  Biomarker Study to Identify Subjects with Advanced Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations

• IRAS ID

  264480

• Contact name

  Dakshinamoorthy Muthukumar

• Contact email

  Muthu.kumar@colchesterhospital.nhs.uk

• Sponsor organisation

  Janssen-Cilag International NV

• Duration of Study in the UK

  1 years, 10 months, 5 days

• Research summary

  This is a biomarker study to identify patients with Urothelial Cancer and selected Fibroblast Growth Factor Receptor (FGFR) gene mutations through molecular testing of their archival tumour tissue. Subjects with Urothelial Cancer who test positive for FGFR mutations may be screened for inclusion in Janssen-sponsored clinical studies testing the use of Erdafitinib.

• REC name

  North West - Preston Research Ethics Committee

• REC reference

  19/NW/0534

• Date of REC Opinion

  13 Sep 2019

• REC opinion

  Further Information Favourable Opinion